Amer Zeidan, MBBS, Associate Professor of Hematology, Yale School of Medicine @YaleCancer explains how oral therapies will impact the treatment landscape in myeloid malignancies.
Oral Therapies in the Treatment of Myeloid Malignancies @YaleCancer
Advertisement